A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection
새로운 글루코코르티코이드 및 안드로겐 수용체 조절제는 SARS-CoV-2 감염의 시리아 햄스터 모델에서 바이러스 진입 및 선천성 면역 염증 반응을 감소시킵니다
Immunology
Published on
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료제,
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료제,
[키워드] 2019-nCoV
2019-nCoV/USA-WA1/2020
ACE2
acting
Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Administered
administration
amplify
Analysis
androgen
Androgen receptor
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
animal
animals
antagonist
antagonists
bind
caused
CD4
Cell
clinical development
Clinical studies
clinical study
coronavirus
COVID-19
Critical
days post-infection
decrease
Defense
domain
dose-dependent
DPI
Efficacy
enzyme
examined
expression
glucocorticoid
Glucocorticoid receptor
golden hamster
hamster
Host
host defense
humans
IL-6
indicated
infiltration
Inflammation
inflammatory lung injury
Inflammatory response
Innate
innate immune
Innate immunity
intranasally
lack
lung
Lung histopathology
Lung injury
lung tissue
Macrophage
macrophages
mechanism
mechanism of action
Model
modulator
molecular docking studies
Molecular docking study
novel
oral administration
outcome
patients
Phylogenetic analysis
positive
Predictive
Prevent
progression
protease
Protein
PT150
receptor
receptors
reduce
regulated
Replication
replication of SARS-CoV-2
required
Research
respiratory
response
Result
SARS – CoV – 2
SARS-CoV-2
SARS-COV-2 infection
sequence identity
Serine
serine 2
severe acute respiratory syndrome Coronavirus
shown
strain
surface protein
T-cell
T-cells
TCID
the cell
therapeutic
therapeutic efficacy
Therapeutics
tissue damage
tissue injury
TMPRSS2
transcriptional repressor
transcriptionally
transmembrane
Treatment
USA-WA1/2020
variants
variants of SARS-CoV-2
Viral
viral entry
Viral load
virus
were infected
[DOI] 10.3389/fimmu.2022.811430 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2022.811430 PMC 바로가기 [Article Type] Immunology